Default Category
-
Dartmouth-Hitchcock Medical Center: Spine Care
Huckman, Robert S.; Porter, Michael E.; Gordon, Rachel; Kindred, NatalieCase HBS-609016-EStrategyDescribes the Spine Center at Dartmouth-Hitchcock Medical Center, a multidisciplinary unit that offers patients suffering from spinal problems "one-stop" access to a range of providers including orthopedic surgeons, neurosurgeons, neurologists, medical specialists in physical medicine and pain management, mental health providers, and occupational and physical therapists. The Center was created to address what its founder, James Weinstein, M.D., s...Starting at €8.20
-
La-Z-Boy (A) (Spanish Version)
Fuller, Joseph B.; Kindred, NatalieCase HBS-317S09StrategyKurt Darrow, CEO de muebles La-Z-Boy, debe decidir si desea continuar una revisión de la estrategia de la compañía en la cara de un colapso de la demanda durante la gran recesión. Tener cartera de marcas y red de fabricación posterior pelado de La-Z-Boy, tiene la intención de cambiar la posición de la compañía como una marca minorista de muebles y modas. dirección sólo está a punto de poner en práctica una nueva estrategia que implica una fuerte ...Starting at €8.20
-
Shanghai Pharmaceuticals
Herzlinger, Regina E.; Kindred, NatalieCase HBS-313016-EStrategyShanghai Pharmaceuticals (SPH), a vertically integrated Chinese pharmaceutical conglomerate, was considering its strategic options in the context of a rapidly evolving industry, policy, and economic environment. The company-essentially a collection of subsidiaries operating under a unified management structure-was formed through the 2009 merger of several state-owned enterprises, part of a broad policy effort in China to streamline state assets, ...Starting at €8.20
-
La-Z-Boy (A)
Fuller, Joseph B.; Kindred, NatalieCase HBS-317034-EStrategyKurt Darrow, CEO of La-Z-Boy furniture, must decide whether to continue an overhaul of the company's strategy in the face of a collapse in demand during the great recession. Having pared back La-Z-Boy's portfolio of brands and manufacturing network, he intends to reposition the company as a branded retailer of furniture and home fashions. Just management is poised to implement a new strategy that involves a heavy investment in brand advertising, ...Starting at €8.20
-
Werfen: prioridades estratégicas del nuevo presidente
Canals Margalef, JorgeCase SM-1663Corporate Governance, StrategyEste caso permite discutir los principales retos estratégicos del nuevo presidente de una empresa familiar de ámbito global.Starting at €8.20
-
Werfen: The New President's Strategic Priorities
Canals Margalef, JorgeCase SM-1663-ECorporate Governance, StrategyThis case allows for discussion of the main strategic challenges facing the new president of a family business with a global reach.Starting at €8.20
-
PromoFarma 2018
Canals Margalef, Jorge; Masclans, R.Case SM-1692-ECorporate Governance, StrategyThis case explores the strategic challenges experienced in 2018 by the founders of PromoFarma, a software company that sells and distributes health and beauty products. In particular, the case raises: - Some strategic decisions needing to be taken - A process of internationalization - The search for future company shareholders - The design of the company's governanceStarting at €8.20
-
Managing Vioxx (A) (Spanish version)
Simons, Robert L.; Rosenberg, Kathryn; Kindred, NatalieCase HBS-111S02Strategy(B) evidence of life-threatening side effects, (C) decision options, (D) announcement to withdraw Vioxx, (E) reaction by patients, shareholders, media, and regulators, (F) Merck fights back, and (G) wrap-up. At the end of the case series, students may conclude that doing the right thing sometimes requires very hard choices.Starting at €8.20
-
Bayer Crop Science
Bell, David E.; McLoughlin, Damien P.; Kindred, Natalie; Barnett, JamesCase HBS-520055-EStrategyIn mid-2019, a year after German conglomerate Bayer Group closed its acquisition of U.S.-based seeds giant Monsanto, the leadership of Bayer's Crop Science division (which absorbed Monsanto) is reflecting on the opportunities ahead. Some observers have questioned Bayer's decision to buy Monsanto, citing potential reputational and financial liabilities; in the last year, Bayer's stock price has suffered. However, the leadership team expects the co...Starting at €8.20
-
PromoFarma
Canals Margalef, Jorge; Masclans, R.Case SM-1692Corporate Governance, StrategyEste caso plantea los retos estratégicos que los fundadores de PromoFarma, una empresa de software que vende y distribuye productos de parafarmacia, tienen en 2018. En particular, el caso plantea: - Unas decisiones estratégicas a tomar - Un proceso de internacionalización - La búsqueda de los futuros accionistas de la empresa - El diseño del gobierno de la empresaStarting at €8.20